Helen of Troy Ltd. (NASDAQ:HELE) shares dropped 2.8% on Friday . The company traded as low as $98.02 and last traded at $99.78, with a volume of 253,247 shares changing hands. The stock had previously closed at $102.69.

HELE has been the topic of a number of research analyst reports. Piper Jaffray Cos. restated an “outperform” rating and set a $110.00 price objective on shares of Helen of Troy in a research report on Wednesday, May 25th. Zacks Investment Research downgraded shares of Helen of Troy from a “hold” rating to a “sell” rating in a research report on Wednesday, May 4th. Finally, Jefferies Group restated a “buy” rating and set a $114.00 price objective on shares of Helen of Troy in a research report on Wednesday.

The firm has a market cap of $2.75 billion and a price-to-earnings ratio of 28.20. The firm has a 50-day moving average of $101.40 and a 200-day moving average of $97.41.

Helen of Troy (NASDAQ:HELE) last posted its quarterly earnings results on Thursday, July 7th. The company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.12 by $0.15. The business earned $347.90 million during the quarter. The business’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the prior year, the company posted $1.06 EPS. Analysts predict that Helen of Troy Ltd. will post $6.13 EPS for the current fiscal year.

In other news, insider Richard J. Oppenheim sold 1,250 shares of Helen of Troy stock in a transaction that occurred on Monday, May 2nd. The shares were sold at an average price of $99.34, for a total value of $124,175.00. Following the transaction, the insider now owns 831 shares of the company’s stock, valued at approximately $82,551.54. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Richard J. Oppenheim sold 500 shares of Helen of Troy stock in a transaction that occurred on Friday, May 6th. The stock was sold at an average price of $97.93, for a total transaction of $48,965.00. Following the completion of the transaction, the insider now directly owns 581 shares in the company, valued at approximately $56,897.33. The disclosure for this sale can be found here.

Other hedge funds and institutional investors have recently modified their holdings of the company. Schroder Investment Management Group increased its position in shares of Helen of Troy by 32.8% in the fourth quarter. Schroder Investment Management Group now owns 167,400 shares of the company’s stock worth $15,778,000 after buying an additional 41,300 shares during the last quarter. Principal Financial Group Inc. increased its position in shares of Helen of Troy by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 191,401 shares of the company’s stock worth $18,039,000 after buying an additional 4,658 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Helen of Troy by 3.7% in the fourth quarter. Wells Fargo & Company MN now owns 293,789 shares of the company’s stock worth $27,690,000 after buying an additional 10,613 shares during the last quarter. Morgan Stanley increased its position in shares of Helen of Troy by 2,056.6% in the fourth quarter. Morgan Stanley now owns 235,204 shares of the company’s stock worth $22,168,000 after buying an additional 224,298 shares during the last quarter. Finally, GSA Capital Partners LLP increased its position in shares of Helen of Troy by 687.9% in the fourth quarter. GSA Capital Partners LLP now owns 17,995 shares of the company’s stock worth $1,696,000 after buying an additional 15,711 shares during the last quarter.

Helen of Troy Limited is a global consumer products company. The Company offers solutions for its customers through a portfolio of brands. It is a global designer, developer, importer, marketer, and distributor of a portfolio of brand-name consumer products. It has four business segments: Housewares, Healthcare/Home Environment, Nutritional Supplements and Personal Care.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.